Testimony Before the FDA’s Vaccines and Related Biological Products Advisory Committee Regarding the Development, Authorization, and Licensure of Vaccines to Prevent COVID-19
In testimony before a meeting of the Food and Drug Administration’s (FDA’s) Vaccines and Related Biological Products Advisory Committee, Public Citizen urged the committee to recommend against issuing an Emergency Use Authorization (EUA) for any vaccine to prevent COVID-19 because the safety and efficacy standards for a vaccine EUA are inadequate.
See Public Citizen’s other work on the coronavirus pandemic.